Arbekacin
Arbekacin
Arbekacin (pronounced: ar-be-ka-cin) is an aminoglycoside antibiotic that is primarily used in the treatment of infections caused by multidrug-resistant bacteria.
Etymology
The name "Arbekacin" is derived from the name of the Japanese company that first developed it, Arbek Co., Ltd., and the class of antibiotics it belongs to, aminoglycosides.
Usage
Arbekacin is used to treat serious infections caused by Gram-negative bacteria that are resistant to other aminoglycosides. It is particularly effective against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.
Mechanism of Action
Arbekacin works by binding to the bacterial ribosome, inhibiting protein synthesis and leading to bacterial cell death. It is also thought to interfere with bacterial cell wall synthesis.
Side Effects
Like other aminoglycosides, Arbekacin can cause nephrotoxicity and ototoxicity. Other potential side effects include allergic reactions, nausea, and vomiting.
Related Terms
- Aminoglycoside
- Antibiotic
- Gram-negative bacteria
- Methicillin-resistant Staphylococcus aureus (MRSA)
- Pseudomonas aeruginosa
- Ribosome
- Nephrotoxicity
- Ototoxicity
External links
- Medical encyclopedia article on Arbekacin
- Wikipedia's article - Arbekacin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski